As of 2025-07-15, the Gross Margin of Hubei Minkang Pharmaceutical Ltd (HBMK) is 42.7%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2013-12-31 | 42.7% |
2012-12-31 | 48.5% |
2011-12-31 | 47.8% |
2011-03-31 | - |
2010-03-31 | - |
2009-03-31 | - |
2008-03-31 | - |
2007-03-31 | - |
- | |
- |